Ryusaku Matsumoto Selected Research

Ryusaku Matsumoto Research Topics

Disease

7	Neoplasms (Cancer) 07/2022 - 11/2016
5	Autoimmune Hypophysitis 11/2019 - 01/2014
4	Hypothyroidism 12/2021 - 09/2014
4	Hypophysitis 12/2021 - 10/2015
4	Acromegaly 10/2019 - 01/2015
3	Cushing Syndrome 09/2020 - 01/2014
2	Adenoma (Adenomas) 07/2022 - 09/2020
2	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 12/2021 - 10/2018
2	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 01/2014
2	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 01/2017
2	Non-alcoholic Fatty Liver Disease 01/2018 - 10/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 01/2014
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2022
1	Pituitary ACTH Hypersecretion 06/2022
1	Thymoma (Thymic Carcinoma) 03/2021
1	Pheochromocytoma 09/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Hyperplasia 01/2020
1	Leiomyoma (Uterine Fibroids) 01/2020
1	Leiomyomatosis 01/2020
1	Myxoma (Myxomas) 01/2020
1	Follicular Adenocarcinoma 10/2019
1	Growth Hormone-Secreting Pituitary Adenoma 10/2019
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 10/2019
1	Glioma (Gliomas) 10/2019
1	Primary Hyperparathyroidism 10/2019
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2019
1	Disease Progression 02/2019
1	Carcinoma (Carcinomatosis) 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Renal Insufficiency (Renal Failure) 01/2018
1	Atrophy 01/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	ACTH-Secreting Pituitary Adenoma 01/2017
1	Inflammation (Inflammations) 10/2016
1	Fibrosis (Cirrhosis) 10/2016
1	Obesity 01/2016
1	Cysts 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 10/2015
1	Polyps 06/2015
1	Adenocarcinoma 06/2015
1	Hypopituitarism (Sheehan's Syndrome) 02/2014
1	Immunoglobulin G4-Related Disease 02/2014
1	Thrombosis (Thrombus) 01/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2014
1	Near Drowning 01/2013

Drug/Important Bio-Agent (IBA)

8	Growth Hormone (Somatotropin)IBA 03/2021 - 09/2014
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 01/2015
4	ProlactinIBA 07/2022 - 09/2014
4	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2022 - 01/2014
4	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2022 - 01/2018
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021 - 09/2014
3	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 06/2015
2	Hormones (Hormone)IBA 07/2022 - 10/2018
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2018
2	LigandsIBA 12/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2020
2	AntibodiesIBA 01/2018 - 09/2014
2	Isolated ACTH DeficiencyIBA 01/2018 - 02/2014
2	Immunoglobulin G (IgG)IBA 10/2015 - 02/2014
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 06/2022
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2021
1	AntigensIBA 12/2021
1	AutoantigensIBA 12/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	ReninIBA 09/2020
1	AldosteroneIBA 09/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2020
1	Fumarate Hydratase (Fumarase)IBA 01/2020
1	S-(2-succinyl)cysteineIBA 01/2020
1	EpitopesIBA 11/2019
1	RacivirIBA 10/2019
1	GlucocorticoidsIBA 02/2019
1	atezolizumabIBA 01/2018
1	Transcription Factor Pit-1 (Transcription Factor Pit 1)IBA 01/2017
1	Choline (Choline Chloride)IBA 10/2016
1	Methionine (L-Methionine)FDA Link 10/2016
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 10/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Insulin-Like PeptidesIBA 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Indicators and Reagents (Reagents)IBA 01/2014
1	AcetylesteraseIBA 01/2014
1	AutoantibodiesIBA 01/2014
1	fibrin fragment D (D-dimer)IBA 01/2014
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2014
1	ElectrolytesIBA 01/2013

Therapy/Procedure

4	Therapeutics 01/2017 - 10/2014
2	Immunotherapy 12/2021 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Radiotherapy 12/2015